Re: Gilead GS-5829 Perspective

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Gilead GS-5829 Perspective

in response to

Re: Gilead GS-5829 Perspective

tada

posted on Jul 24, 2017 12:41PM

Well that would be welcome news , We have waited a hell of a long time for any type of major deal, I would think Pfizer would be one of the parties at the table doing the dance with Zenith if the results are that stellar....

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply